Max Marchione on Retatrutide, a Post-Obesity Society, and Aging Therapeutics | MTS Live
Max Marchione joins MTS to discuss the retatrutide Phase 3 trial results and what nearly one-third body weight loss means for the future of obesity treatment. He covers the growing menu of GLP-1 options, the tradeoffs between fat loss and muscle preservation, and what a post-obesity world might mean for culture, dating, and looksmaxing. He also addresses the longer arc toward genomic medicine as the next major therapeutic frontier.--https://x.com/maxmarchione
--
MTS is a live news and interview show covering technology, business, politics, and culture as it happens.
Follow MTS:
X |…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.